Triperiden
Triperiden is an inhibitor of influenza virus multiplication. Triperiden targets the haemagglutinin of fowl plague virus (FPV) for antiviral activity and acts by inhibiting the conformational change in the haemagglutinin at acid pH. Triperiden is also anticholinergic anti-parkinsonism agent[1].
Product Specifications
CAS Number
14617-17-5
UNSPSC
12352005
Target
Influenza Virus
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/triperiden.html
Purity
99.88
Solubility
DMSO : 33.33 mg/mL (ultrasonic)
Smiles
OC(C1C2C3C2CC1C3)(C4=CC=CC=C4)CCN5CCCCC5.Cl
Molecular Formula
C21H30ClNO
Molecular Weight
347.92
References & Citations
[1]Ghendon Y, et al. Haemagglutinin of influenza A virus is a target for the antiviral effect of Norakin. J Gen Virol. 1986;67 (Pt 6) :1115-1122.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD163 (Monocyte & Macrophage Marker) (M130/2162), CF405S conjugate, 0.1mg/mL
Protein A Coated - 96 well Solid plates - Clear PS
RNASE12 (NM_001024822) Human Over-expression Lysate
